Monthly Archives: January 2018

Global Smallpox Drugs and Companies Pipeline Review H1 2018

Pune, India, 31st January 2018: WiseGuyReports announced addition of new report, titled “Smallpox – Pipeline Review, H1 2018”.

Pune, India – January 31, 2018 /MarketersMedia/ —

Summary
Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, prostration, severe back pain, abdominal pain and vomiting. This is followed by the development of rashes on the face, hands, forearms and the trunk. Lesions develop in the mucous membranes of the nose and mouth which ulcerate, releasing large amounts of virus into the mouth and throat. Treatment includes medications such as antiviral and lifestyle modification.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2841818-smallpox-pipeline-review-h1-2018

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Smallpox – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Smallpox (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Preclinical and Discovery stages are 1, 2, 6 and 4 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Smallpox (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Smallpox (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Smallpox (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Smallpox (Infectious Disease) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Smallpox (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Smallpox (Infectious Disease)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Smallpox (Infectious Disease).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Smallpox (Infectious Disease) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
List of Tables
List of Figures
Introduction
Smallpox – Overview
Smallpox – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Smallpox – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2841818-smallpox-pipeline-review-h1-2018

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/global-smallpox-drugs-and-companies-pipeline-review-h1-2018/294668

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 294668

Global Drum Filling System Industry Sales, Revenue, Gross Margin, Market Share, by Regions (2013-2025)

Global Drum Filling System Market Research Report 2018 contains historic data that spans 2013 to 2016, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry.

Pune, India – January 31, 2018 /MarketersMedia/ —

Global Drum Filling System Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Drum Filling System. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Drum Filling System market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Drum Filling System Market is headed.

Access complete report at: https://www.themarketreports.com/report/global-drum-filling-system-sales-market-report-2018

With this Drum Filling System Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Mettler Toledo, Palamatic Process, Feige, Drumeo Edge, Nbe, Inc, Powder Systems Limited, Precia Molen, Apacks, Epic Packaging Systems, Inline Filling Systems, Jay Instruments, Specialty Equipment, Erie Technical Systems, Inc and others.

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/896728

When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn’t shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Drum Filling System Industry, per application.

All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/896728

List of Chapters:
1 Drum Filling System Market Overview
2 Global Drum Filling System Competition by Players/Suppliers, Type and Application
3 United States Drum Filling System (Volume, Value and Sales Price)
4 China Drum Filling System (Volume, Value and Sales Price)
5 Europe Drum Filling System (Volume, Value and Sales Price)
6 Japan Drum Filling System (Volume, Value and Sales Price)
7 Southeast Asia Drum Filling System (Volume, Value and Sales Price)
8 India Drum Filling System (Volume, Value and Sales Price)
9 Global Drum Filling System Players/Suppliers Profiles and Sales Data
10 Drum Filling System Manufacturing Cost Analysis
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
13 Market Effect Factors Analysis
14 Global Drum Filling System Market Forecast (2018-2025)
15 Research Findings and Conclusion
16 Appendix

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-drum-filling-system-industry-sales-revenue-gross-margin-market-share-by-regions-2013-2025/294652

For more information, please visit https://www.themarketreports.com/report/global-drum-filling-system-sales-market-report-2018

Source: MarketersMedia

Release ID: 294652

Global Enterprise Session Border Controller Market Supply, Sales, Revenue and Forecast from 2018 to 2025

Global Enterprise Session Border Controller Market Research Report 2018 contains historic data that spans 2013 to 2016, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry.

Pune, India – January 31, 2018 /MarketersMedia/ —

Global Enterprise Session Border Controller Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Enterprise Session Border Controller. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Enterprise Session Border Controller market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Enterprise Session Border Controller Market is headed.

Access complete report at: https://www.themarketreports.com/report/global-enterprise-session-border-controller-sales-market-report-2018

With this Enterprise Session Border Controller Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Audiocodes, Sonus Networks, Inc., Oracle Corporation, Cisco Systems, Inc., Edgewater Networks Inc., Avaya Inc., Adtran, Inc., Patton Electronics Co., Ingate Systems Ab, Genband, Dialogic, Italtel, Innomedia, Media5, Sangoma, Unify and others.

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/896741

When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn’t shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Enterprise Session Border Controller Industry, per application.

All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/896741

List of Chapters:
1 Enterprise Session Border Controller Market Overview
2 Global Enterprise Session Border Controller Competition by Players/Suppliers, Type and Application
3 United States Enterprise Session Border Controller (Volume, Value and Sales Price)
4 China Enterprise Session Border Controller (Volume, Value and Sales Price)
5 Europe Enterprise Session Border Controller (Volume, Value and Sales Price)
6 Japan Enterprise Session Border Controller (Volume, Value and Sales Price)
7 Southeast Asia Enterprise Session Border Controller (Volume, Value and Sales Price)
8 India Enterprise Session Border Controller (Volume, Value and Sales Price)
9 Global Enterprise Session Border Controller Players/Suppliers Profiles and Sales Data
10 Enterprise Session Border Controller Manufacturing Cost Analysis
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
13 Market Effect Factors Analysis
14 Global Enterprise Session Border Controller Market Forecast (2018-2025)
15 Research Findings and Conclusion
16 Appendix

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-enterprise-session-border-controller-market-supply-sales-revenue-and-forecast-from-2018-to-2025/294656

For more information, please visit https://www.themarketreports.com/report/global-enterprise-session-border-controller-sales-market-report-2018

Source: MarketersMedia

Release ID: 294656

Global Epoxy Surface Coatings Industry Analysis, Size, Market share, Growth, Trend and Forecast 2025

Global Epoxy Surface Coatings Market Research Report 2018 contains historic data that spans 2013 to 2016, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry.

Pune, India – January 31, 2018 /MarketersMedia/ —

Global Epoxy Surface Coatings Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Epoxy Surface Coatings. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Epoxy Surface Coatings market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Epoxy Surface Coatings Market is headed.

Access complete report at: https://www.themarketreports.com/report/global-epoxy-surface-coatings-sales-market-report-2018

With this Epoxy Surface Coatings Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Akzo Nobel, Henkel, Basf, Kansai Nerolac, Sika Ag, Ppg Industries, Rpm International, The Valspar Corp, Axalta Coating Systems, The Sherwin-Williams Company and others.

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/896743

When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn’t shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Epoxy Surface Coatings Industry, per application.

All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/896743

List of Chapters:
1 Epoxy Surface Coatings Market Overview
2 Global Epoxy Surface Coatings Competition by Players/Suppliers, Type and Application
3 United States Epoxy Surface Coatings (Volume, Value and Sales Price)
4 China Epoxy Surface Coatings (Volume, Value and Sales Price)
5 Europe Epoxy Surface Coatings (Volume, Value and Sales Price)
6 Japan Epoxy Surface Coatings (Volume, Value and Sales Price)
7 Southeast Asia Epoxy Surface Coatings (Volume, Value and Sales Price)
8 India Epoxy Surface Coatings (Volume, Value and Sales Price)
9 Global Epoxy Surface Coatings Players/Suppliers Profiles and Sales Data
10 Epoxy Surface Coatings Manufacturing Cost Analysis
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
13 Market Effect Factors Analysis
14 Global Epoxy Surface Coatings Market Forecast (2018-2025)
15 Research Findings and Conclusion
16 Appendix

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-epoxy-surface-coatings-industry-analysis-size-market-share-growth-trend-and-forecast-2025/294661

For more information, please visit https://www.themarketreports.com/report/global-epoxy-surface-coatings-sales-market-report-2018

Source: MarketersMedia

Release ID: 294661

Blog Exposure – ING Acquires 75% Controlling Stake in Omnichannel Payments Service Provider Payvision

Stock Monitor: Principal Financial Group Post Earnings Reporting

LONDON, UK / ACCESSWIRE / January 31, 2018 / Active-Investors.com has just released a free research report on ING Groep N.V. (NYSE: ING). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ING as the Company’s latest news hit the wire. On January 29, 2018, the Company announced that it has acquired a controlling 75% stake in Amsterdam, the Netherlands-based Payvision. ING’s shared that Payvision’s total worth was €360 million (approximately $447.4 million), however the Company did not disclose the value of ING’s investment in Payvision. The strategic deal will allow ING to expand its omnichannel payments offerings in the payments processing market especially in the e-commerce segment. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Principal Financial Group, Inc. (NASDAQ: PFG), which also belongs to the Financial sector as the Company ING Groep. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=PFG

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, ING Groep most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ING

Highlights of the transaction

As per the agreement signed by ING and Payvision, ING will acquire 75% stake while Payvision’s founding management team will retain the balance 25% stake. Payvision’s existing management team is also expected to continue managing the business operations of the Company. The deal is expected to close in Q1 2018. ING expects that the deal will not have a material impact on its CET 1 ratio. CET 1 (Common Equity Tier 1) ratio indicates the financial strength of a Bank and gives an overall view of Funding Risk.

Commenting on acquiring controlling stake in Payvision, Ralph Hamers, CEO of ING, said:

“The payments sector is one of the most dynamic areas of the financial services industry. In order to stay a step ahead, ING has to constantly innovate. We do that by starting up our own ventures and by strategically taking minority or majority stakes. Payvision’s founding team has developed a great business with a proven technology in an area where ING wants to grow. We are confident our customers will strongly benefit from this investment.”

Rudolf Booker, founder and CEO of Payvision, added:

“This investment in the payments market, made by one of the world’s most innovative financial and banking services brands, acknowledges our vision to deliver leading payments capabilities to support customers maximize their revenues.”

Benefits of the deal

For ING, the deal will allow it to leverage Payvision’s technology platform to complements its lending and working capital solutions and expand its global distribution network. ING will be able to offer it merchant customers a payments platform that offers customized payments solutions designed for the fast-paced international retail environment.

Currently, Payvision’s payments platform supports more than 80 payment methods covering 150+ currencies including Maestro, Visa, iDEAL, Alipay, JCB, Mastercard, PayPal, and Union Pay. The deal allows ING’s business customers to accept all types of payments via any channel, including in-store terminals and ecommerce sites and through any device and from anywhere in the world. The user-friendliness and a uniform shopping experience on Payvision platform is sure to increase frequency of purchases. Merchants can easily track and manage all their payments across geographies through a single platform. Payvision’s platform provides merchants with data and analytics as it can be connected to their accounting software which can help them taking informed business decisions and increase revenue and decrease costs. The best feature of Payvision’s platform is that it is a faster and safer and offers better protection against fraud and risk.

For Payvision, the investment from ING will allow it to support its ambitious growth plans, expand its payment product portfolio, and develop its global network.

About Payvision

Founded in 2002, Payvision is a fast-growing, independent international omnichannel payments service provider. Its payments platform connects payment service providers with global merchants. Payvision launched Acapture in 2015, a new data-driven payment service provider to cater to the omnichannel and cross-border payments needs of merchants. The Company has extensive experience in the global payments market and vast knowledge of ecommerce payments processing. Payvision has offices in 10 cities in the US, Europe, Asia, and the Pacific.

About ING Groep N.V.

Amsterdam, The Netherlands-based ING is a global financial institution with a strong European base, offering banking services via ING Bank. ING Bank offers offer retail and wholesale banking services to customers in over 40 countries. It is supported by a team of over 51,000 employees who service 36.9 million customers, of which 10.5 million were primary customers (as on September 30, 2017).

ING Group’s shares are listed on the Amsterdam, Brussels, and on the NYSE (New York Stock Exchange) and its shares are being included in the FTSE4Good index and in the Dow Jones Sustainability Index (Europe and World) where ING is among the leaders in the Banks industry group.

Stock Performance Snapshot

January 30, 2018 – At Tuesday’s closing bell, ING Groep’s stock fell 1.24%, ending the trading session at $19.99.

Volume traded for the day: 5.22 million shares, which was above the 3-month average volume of 2.73 million shares.

Stock performance in the last month – up 8.00%; previous three-month period – up 8.35%; past twelve-month period – up 39.40%; and year-to-date – up 8.29%

After yesterday’s close, ING Groep’s market cap was at $77.65 billion.

Price to Earnings (P/E) ratio was at 13.51.

The stock has a dividend yield of 2.85%.

The stock is part of the Financial sector, categorized under the Life Insurance industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 487426

Free Research Report as Intel Reported Record Quarterly Revenues; Adjusted EPS Soared 37%

Stock Monitor: GSI Technology Post Earnings Reporting

LONDON, UK / ACCESSWIRE / January 31, 2018 / Active-Investors.com has just released a free earnings report on Intel Corp. (NASDAQ: INTC). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=INTC. The Company reported its fourth quarter fiscal 2017 and full fiscal year 2017 operating and financial results on January 25, 2018. The world’s largest chipmaker outperformed top- and bottom-line expectations, and raised its dividend by 10%. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for GSI Technology, Inc. (NASDAQ: GSIT), which also belongs to the Technology sector as the Company Intel. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=GSIT

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Intel most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=INTC

Earnings Highlights and Summary

For Q4 2017, Intel generated a record fourth-quarter revenue of $17.1 billion, up 4% compared to $16.4 billion in Q4 2016. Excluding McAfee, the Company’s reported quarter revenue grew 8% on a y-o-y basis, and topped analysts’ estimates of $16.31 billion.

For FY17, Intel posted a record full-year revenue of $62.8 billion, reflecting a growth of 6% compared to $59.4 billion in FY16. Excluding McAfee, the Company’s full-year revenue grew 9% on a y-o-y basis.

During Q4 2017, Intel’s operating results reflected an income tax expense of $5.4 billion as a result of the US corporate tax reform enacted in December 2017, including a one-time required transition tax on the Company’s previously untaxed foreign earnings, which was partially offset by the re-measurement of deferred taxes using the new US statutory tax rate. Intel is forecasting a tax rate of 14% for FY18.

For Q4 2017, Intel reported a GAAP net loss of $0.7 billion, or $0.15 loss per diluted share, compared to a GAAP net income of $3.6 billion, or $0.73 per diluted share, in Q4 2016. On a non-GAAP basis, the Company posted earnings of $5.2 billion, or $1.08 per share, up 34% and 37% on a y-o-y basis, respectively. Intel’s earnings smashed past Wall Street’s expectations of $0.86 per share.

For FY17, Intel posted a GAAP net income of $9.6 billion, or $1.99 per diluted share, compared to a GAAP net income of $10.3 billion, or $2.12 per diluted share, in FY16. On a non-GAAP basis, the Company posted earnings of $16.8 billion, or $3.46 per share, compared to $13.2 billion, or $2.72 per share, in FY16.

Segment Results

During Q4 2017, Intel reported strong performance from data-centric businesses, comprised of Programmable Solutions Group (PSG) and Non-Volatile Memory Solutions Group (NSG), which accounted for 47% of the Company’s revenue in the reported quarter, an all-time high. In the reported quarter, the Company’s Data Center Group (DCG), Internet of Things Group (IOTG), and PSG achieved record quarterly revenues.

For Q4 2017, Intel’s Client Computing Group (CCG) reported revenues of $9.0 billion, down 2% on a y-o-y basis. The segment shipped a record volume of Intel® Core™ i7 processors, launched the new 8th Gen Intel® Core™ processor with Radeon™ RX Vega M Graphics, and announced an expanding line-up of LTE and 5G multi-mode modems. The Company’s DCG’s revenues surged 20% to $5.6 billion on a y-o-y basis, while IOTG reported revenues of $879 million, reflecting a growth of 21% compared to the year ago same period.

During Q4 2017, Intel’s NSG’s revenue advanced 9% to $889 million on a y-o-y basis. In the reported quarter, NSG launched the new Intel® Optane™ SSD DC P4800X Series for the data center. The Company’s PSG’s revenue soared 35% to $568 million on a y-o-y basis.

Cash Matters

In 2017, Intel generated a record $22 billion cash from operations, and returned nearly $9 billion to shareholders.

The Company also announced that its Board of Directors has approved an increase in its cash dividend to $1.20 per share on an annual basis, reflecting a 10% increase. The Board declared a quarterly dividend of $0.30 per share on Intel’s common stock, which will be payable on March 01, 2018, to shareholders of record as on February 07, 2018.

Outlook

For the first quarter of the fiscal year 2018, Intel is forecasting revenues of $15.0 billion, plus or minus $500 million. The Company is estimating GAAP earnings of $0.65 and non-GAAP earnings of $0.70, both plus or minus $0.05 per share.

For the full fiscal year 2018, Intel is projecting revenues in the range of $64 billion to $66 billion, while the Company is anticipating GAAP earnings of $3.30 per share and non-GAAP earnings of $4.55 per share, both plus or minus 5%.

Stock Performance Snapshot

January 30, 2018 – At Tuesday’s closing bell, Intel’s stock dropped 2.38%, ending the trading session at $48.79.

Volume traded for the day: 32.63 million shares.

Stock performance in the last month – up 5.56%; previous three-month period – up 9.89%; past twelve-month period – up 30.38%; and year-to-date – up 5.70%

After yesterday’s close, Intel’s market cap was at $228.48 billion.

Price to Earnings (P/E) ratio was at 17.10.

The stock has a dividend yield of 2.23%.

The stock is part of the Technology sector, categorized under the Semiconductor – Broad Line industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 487427

Blog Exposure – ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium

Stock Monitor: Alliance Data Systems Post Earnings Reporting

LONDON, UK / ACCESSWIRE / January 31, 2018 / Active-Investors.com has just released a free research report on ITUS Corp. (NASDAQ: ITUS).If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ITUS as the Company’s latest news hit the wire. On January 29, 2018, the Company, which is a cancer-focused biotechnology organization, announced that it presented positive data from its ongoing study about its early cancer detection technology at the American Society of Clinical Oncology – Society for Immunotherapy of Cancer (ASCO-SITC) Clinical Immuno-Oncology Symposium in San Francisco, California, on January 26, 2018. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Alliance Data Systems Corporation (NYSE: ADS), which also belongs to the Services sector as the Company ITUS Corp. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=ADS

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, ITUS Corp. most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ITUS

The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting that emphasizes on clinical and translational research in immuno-oncology and the implications for clinical care. The data was presented via a poster presentation titled ‘The coupling of MDSCs with a computational analytic method to detect solid tumors’. It highlighted ITUS’ proprietary CchekTM platform that combines the analysis of myeloid-derived suppressor cells (MDSCs) and other subsets of white blood cells with Artificial Intelligence (AI), specifically a neural network (NN), to monitor the patient’s immune system.

Working Towards Early Detection of Cancer

It is well known that when cancer is detected early, that is in Stage I or II, the probability of long-term survival is more than 95%, or even 100% in some cases. But if cancer is detected late, that is Stage III or IV, the chances of long-term survival falls to as low as 10%. Therefore, scientific and investment community show substantial interest in the development of techniques for early cancer detection.

ITUS’ wholly-owned subsidiary, Anixa Diagnostics Corp., is developing the CchekTM platform, which is a series of non-invasive blood tests for the early detection of solid tumor based cancers. It is based on the body’s immunological response to the presence of a malignancy.

Research suggests that there is a dynamic interaction between a patient’s immune system and the existence of a tumor. This interaction leads to subtle changes in the immune system that can be calculated by monitoring and counting circulating white blood cells by using a common laboratory technique known as flow cytometry. Though, simply counting specific cells is not enough to differentiate between a tumor-bearing patient and a healthy individual. However, implementing a neural network to assess the subtle changes and patterns found within the immune system helps the Company to achieve high sensitivity and specificity, which are measures of accuracy of the test.

About the Ongoing Study

The ongoing study enrolled a total of 163 patients, which included 81 cancer patients and 82 healthy donors. As part of the study, collaborators such as the MD Anderson Cancer Center at Cooper, The University of Pennsylvania-Abramson Cancer Center, Virtua Hospital Group, Delaware Valley Urology, and the Wistar Institute provided patient blood samples. Most of the samples collected were from breast cancer and prostate cancer patients, although several other types were also included.
Results from this study supplement the data from the Company’s first cohort, which was released in December 2016. Both these studies were done un-blinded. In the previous study, ITUS reported sensitivity of 92% and specificity of 92%. In this study, it reported a sensitivity of 89% and a specificity of 95%. This little decline in sensitivity is within the margin of error and probably reflects the inclusion of more early stage cancer patients. All cancer patients were biopsy-verified with all clinical stages (I – IV) included. The Area Under the Receiver Operating Characteristic Curve (AUROC), which is a measure of accuracy, was 0.97. It must be noted that AUROC values near 0.50 are poor, while a value greater than 0.90 is considered outstanding.

Technique Can Identify Any Individual With Cancer Regardless Of Tumor Type

The immune system undergoes changes regardless of the location of the tumor and, thus, the patterns indicative of a tumor should exist regardless of the type. The previous study validated that the CchekTM technology works successfully with 15 different types of tumors. Now that additional cancers were included in the study, it shows that ITUS’ technology works with 20 types of cancer from solid tumors. This includes tumors of breast, prostate, lung, colon, pancreatic, melanoma, ovarian, liver, bladder, cervical, endometrial/uterine, gastric, head and neck, testicular, thyroid, osteosarcoma (bone cancer), leiomyosarcoma (cancer of the soft tissue), liposarcoma (cancer of the connective tissue), vulvar, and appendiceal.

Artificial Intelligence Better Than Human Experts

It appears that ITUS’ proprietary AI application is better at making the calls than experienced scientists or physicians. Neutral networks have extraordinary ability to train and analyze the data. One of the most favorable attributes of AI and neural networks is its ability to continuously learn and improve over time in answering the question asked of them. This implies that adding more data would improve the performance further.

ITUS’ Future Plans

Dr. Amit Kumar, President and Chief Executive Officer (CEO) at ITUS, expressed that his team looks forward to publishing this data and also sharing data from other ongoing studies. Besides, he also shared that ITUS’ recently allowed patented claims would help the Company properly protect its technology. At present, ITUS is the only Company that is developing a liquid biopsy diagnostic that incorporates flow cytometry data and AI. He also stated that it is too soon to set the final price for the test but he estimates a price of less than $200.

Stock Performance Snapshot

January 30, 2018 – At Tuesday’s closing bell, ITUS Corp.’s stock fell 2.17%, ending the trading session at $4.05.

Volume traded for the day: 1.62 million shares, which was above the 3-month average volume of 926.82 thousand shares.

Stock performance in the last month – up 65.31%; previous three-month period – up 104.55%; past six-month period – up 412.66%; and year-to-date – up 71.61%

After yesterday’s close, ITUS Corp.’s market cap was at $62.57 million.

The stock is part of the Services sector, categorized under the Business Services industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 487429

Global Wound Care Market Analysis, Size, Share, Trends and Forecast 2023 by Products Types, Wound Types, End Users and Key Players

Premium market research report on “Global Wound Care Market Research Report and Forecast to 2018-2023” is available on Orbis Research.

Dallas, United States – January 31, 2018 /MarketersMedia/ —

According to the Global Wound Care Market report, the Wound Care Market accounted a value of $18.22 billion in 2016 and is projected to reach a value $26.24 billion at the end of 2023. The Global Wound Care Market report covers the Wound Care Market in a comprehensive manner, across all parameters such as types, applications, users, top players, and regions. The report further covers the drivers, restraints and trends in the Wound Care Market for the customer to understand the intricacies of the Wound Care Market which will help them create an efficient plan of action to grow at the fastest rate across the globe.

Browse The Report: http://orbisresearch.com/reports/index/wound-care-global-market-outlook-2017-2023

The Global Wound Care Market is expected to keep rising at a CAGR of 5.3% for the forecast period of 2017 – 2023. The Global Wound Care Market report provides the customer an accurate analysis of the Wound Care Market to assist them in planning their market entry or expansion. The forecast projection is compiled by a team of subject matter experts and market research professionals to ensure that the information is accurate and presented in an easy to consume tables, charts, and graphs.

For the customer to be able to plan for a significant period, the Global Wound Care Market report covers projections up to 2023. The current market scenarios and laws under which the market operates in make it easier to understand how the market will play out for the forecast period. The current trends in the market and the drivers and restrains affecting the market might change with the times.

The top players covered in the report include the following:
Covidien PLC (A Subsidiary of Medtronic Company), Convatec Healthcare B S.À.R.L., Integra LifeSciences, Hollister, Inc., Ethicon, Inc. (A Subsidiary of Johnson & Johnson), Derma Sciences, Inc., Mölnlycke Health Care AB (Subsidiary of Investor AB), Smith & Nephew PLC, Coloplast A/S, BSN medical, Baxter International Inc., 3M Company and Acelity L.P. Inc.

Request a Free Sample of The Report: http://orbisresearch.com/contacts/request-sample/2028289

The report covers a detailed analysis of each majorly impacting player in the Wound Care Market such as the company profile, the latest developments by the player in the Wound Care Market, and the product portfolio of the player currently available in the Wound Care Market, as well as the regions they operate in majorly.

Products Covered:
Exudate Management
Infection Management
Wound Management Products
Surgical Wound Care Products
Traditional and Basic Wound Care Products

Wound Types Covered:
Radionecrosis
Trauma Lacerations
Surgical Wounds
Chronic Wounds & Ulcers
Burns
Acute Wounds

End Users Covered:
Home Healthcare
Long-Term Care Facilities
Hospitals and Specialty Wound Clinics

The regions covered in the Global Wound Care Market report include North America (US, Canada, Mexico), Europe (Germany, UK, Italy, France, Spain, Rest of Europe), Asia Pacific (Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific), South America (Argentina, Brazil, Chile, Rest of South America), and Middle East & Africa (Saudi Arabia, UAE, Qatar, South Africa, Rest of Middle East & Africa).

The Global Wound Care Market report covers the SWOT analysis of the Wound Care Market along with key developments in the market that will be helpful for the customer. Anyone with either academic of business interest in the Wound Care Market, the report will definitely by handy.

Buy The Report@http://orbisresearch.com/contact/purchase/2028289

Major Points From The Table Of Contents:
Executive Summary
Preface
Market Trend Analysis
Porters Five Force Analysis
Global Wound Care market, By Product
Global Wound Care market, By Wound Type
Global Wound Care market, By End User
Global Wound Care Market, By Geography
Key Developments
Company Profiling

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: https://marketersmedia.com/global-wound-care-market-analysis-size-share-trends-and-forecast-2023-by-products-types-wound-types-end-users-and-key-players/294534

For more information, please visit http://orbisresearch.com/reports/index/wound-care-global-market-outlook-2017-2023

Source: MarketersMedia

Release ID: 294534

Natural Coconut Oil Market and Olive Oil Market: 2018 Global Trends, Growth Analysis, Business Opportunity and Regional Forecast to 2025

Research study on “Global Olive Oil Industry and Global Natural Coconut Oil Market” published at Orbisresearch.com which includes Manufacturers, Key Regions and Applications.

Dallas, U.S.A – January 31, 2018 /MarketersMedia/ —

The Global Natural Coconut Oil Market is currently enjoying staggering growth rate owing to the rising global population, increased yields, and improved logistics and supply chain across the globe. The increased purchasing power and the modernization of storage and transport have helped push the Natural Coconut Oil Market to larger heights. Though environment concerns still loom strong over the feasibility of the Natural Coconut Oil Market as the storage for longer durations and the overall yield is going to be an issue to look towards in the Natural Coconut Oil Industry. Yet the Global Natural Coconut Oil Market is expected to continue it strong upward move with a high CAGR year-on-year.

The Global Natural Coconut Oil Market report for 2018 – 2025 has the complete and accurate forecast projections of the Natural Coconut Oil Industry across all segmentations such as type, applications, region, and key players, among others. The Global Natural Coconut Oil Market report provides the customer key insights into the Natural Coconut Oil Industry with detailed statistics such as the growth rate, the market value and volume, and the various segmentations and its detailed analysis.

In terms of type, this report is segmented into the following:
• Virgin Coconut Oil
• Extra Virgin Coconut Oil

The Global Natural Coconut Oil Market report includes the type which has the largest share in the Natural Coconut Oil Market as well as the one with the type with the fastest growth trajectory along with their detailed analysis. The types in the Global Natural Coconut Oil Market are largely dependent on the applications in the Natural Coconut Oil Industry. Hence the report further covers the applications in the Natural Coconut Oil Market as follows:
• Food
• Cosmetics
• Pharmaceuticals
• Others

Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2062183 .

The report assists the customer in understands the competitive landscape in the Global Natural Coconut Oil Market through the coverage on the key players in the Natural Coconut Oil Industry. This information hold key for the customer as the latest developments such as new acquisitions and mergers, as well as any new developments from the companies are covered in the Global Natural Coconut Oil Market report. A detailed company profile and their new products are all covered in the Global Natural Coconut Oil Industry report.

Some of the top players covered in the Natural Coconut Oil Market include:
• NMK Holdings (Pvt) Ltd
• Greenville Agro Corporation
• P.T. Harvard Cocopro
• NATUROCA
• SUN BIO NATURALS (INDIA) PRIVATE LTD
• Celebes
• Sakthi Exports
• Nature Pacific
• Cocomate
• Manchiee De Coco
• KKP Industry
• Genius Nature Herbs Pvt Ltd
• Keratech
• Harin Bio-Tech

In terms of regional performance analysis, the Natural Coconut Oil Market is segmented into the following:
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

The report provides the customer with regional analysis of the Global Natural Coconut Oil Market as to which is the region with the largest growth rate and the most matured market along with all the relevant statistical data.
For the forecast period of 2018 – 2025, the Natural Coconut Oil Market performance and its expected value and volume has been covered in the Global Natural Coconut Oil Market report. Customer looking to gain practical, actionable insights can purchase this report.

Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2062183 .

Some Points from Table of Content:
Chapter One: Natural Coconut Oil Market Overview
Chapter Two: Global Natural Coconut Oil Market Competition by Manufacturers
Chapter Three: Global Natural Coconut Oil Capacity, Production, Revenue (Value) by Region (2013-2018)
Chapter Four: Global Natural Coconut Oil Supply (Production), Consumption, Export, Import by Region (2013-2018)
Chapter Five: Global Natural Coconut Oil Production, Revenue (Value), Price Trend by Type
Chapter Six: Global Natural Coconut Oil Market Analysis by Application
Chapter Seven: Global Natural Coconut Oil Manufacturers Profiles/Analysis
Chapter Eight: Natural Coconut Oil Manufacturing Cost Analysis
….Continued

Global Olive Oil Industry :
The 2018 market research report on Global Olive Oil Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge. The report will shed light on many critical points and trends of the industry which are useful for our esteemed clients. The report covers a vast expanse of information including an overview, comprehensive analysis, definitions and classifications, applications, and expert opinions, among others. With the extent of information filled in the report, the presentation and style of the Global Olive Oil Market report is a noteworthy.

Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2061604 .

The Global Olive Oil Industry report provides key information about the industry, including invaluable facts and figures, expert opinions, and the latest developments across the globe. Not only does the report cover a holistic view of the industry from a global standpoint, but it also covers individual regions and their development. The Global Olive Oil Industry report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The key players covered in the report provide a detailed analysis of the competition and their developments in the Global Olive Oil Industry. Accurate forecasts and expert opinion from credible sources, and the recent R&D development in the industry is also a mainstay of the Olive Oil Market report.

Some Points from Table of Content:
Chapter One: Olive Oil Market Overview
Chapter Two: Global Olive Oil Market Competition by Manufacturers
Chapter Three: Global Olive Oil Capacity, Production, Revenue (Value) by Region (2013-2018)
…..Continued

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research

Source URL: https://marketersmedia.com/natural-coconut-oil-market-and-olive-oil-market-2018-global-trends-growth-analysis-business-opportunity-and-regional-forecast-to-2025/294555

For more information, please visit http://orbisresearch.com/reports/index/2018-market-research-report-on-global-natural-coconut-oil-industry

Source: MarketersMedia

Release ID: 294555

Botox Market 2018-2023: Global Demand, Trend, Key Manufacturers, Growth, Supply Analysis and Industry Forecast Report

Latest Report Available at Orbis research Botox Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth

Dallas, U.S.A – January 31, 2018 /MarketersMedia/ —

Request sample copy of this report @
http://orbisresearch.com/contacts/request-sample/2044081

In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new report on Global Botox Market is confident in meeting their needs and expectations. The 2018 market research report on Global Botox Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge. The report will shed light on many critical points and trends of the industry which are useful for our esteemed clients. The report covers a vast expanse of information including an overview, comprehensive analysis, definitions and classifications, applications, and expert opinions, among others. With the extent of information filled in the report, the presentation and style of the Global Botox Market report is a noteworthy.

The Global Botox Industry report provides key information about the industry, including invaluable facts and figures, expert opinions, and the latest developments across the globe. Not only does the report cover a holistic view of the industry from a global standpoint, but it also covers individual regions and their development. The Global Botox Industry report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The key players covered in the report provide a detailed analysis of the competition and their developments in the Global Botox Industry. Accurate forecasts and expert opinion from credible sources, and the recent R&D development in the industry is also a mainstay of the Botox Market report.

The report also focuses on the significance of industry chain analysis and all variables, both upstream and downstream. These include equipment and raw materials, client surveys, marketing channels, and industry trends and proposals. Other significant information covering consumption, key regions and distributors, and raw material suppliers are also a covered in this report.

Finally, the Botox Market report ends with a detailed SWOT analysis of the market, investment feasibility and returns, and development trends and forecasts. As with every report on Orbis Research, the Botox Industry is the holy grail of information which serious knowledge seekers can benefit from. The report which is the result of ultimate dedication of pedigree professionals has a wealth of information which can benefit anyone, irrespective of their commercial or academic interest.

Browse Complete Report @ http://orbisresearch.com/reports/index/2018-market-research-report-on-global-botox-industry

Some points from TOC:
Chapter One: Botox Market Overview
1.1. Product Overview and Scope of Botox
1.2. Botox Segment by Type (Product Category)
1.2.1. Global Botox Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2. Global Botox Production Market Share by Type (Product Category) in 2017
1.2.3. 50U
1.2.4. 100U
1.2.5. Others
1.3. Global Botox Segment by Application
1.3.1. Botox Consumption (Sales) Comparison by Application (2013-2025)
1.3.2. Medical
1.3.3. Cosmetic
1.4. Global Botox Market by Region (2013-2025)
1.4.1. Global Botox Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2. North America Status and Prospect (2013-2025)
1.4.3. Europe Status and Prospect (2013-2025)
1.4.4. China Status and Prospect (2013-2025)
1.4.5. Japan Status and Prospect (2013-2025)
1.4.6. Southeast Asia Status and Prospect (2013-2025)
1.4.7. India Status and Prospect (2013-2025)
1.5. Global Market Size (Value) of Botox (2013-2025)
1.5.1. Global Botox Revenue Status and Outlook (2013-2025)
1.5.2. Global Botox Capacity, Production Status and Outlook (2013-2025)

Chapter Two: Global Botox Market Competition by Manufacturers
2.1. Global Botox Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1. Global Botox Capacity and Share by Manufacturers (2013-2018)
2.1.2. Global Botox Production and Share by Manufacturers (2013-2018)
2.2. Global Botox Revenue and Share by Manufacturers (2013-2018)
2.3. Global Botox Average Price by Manufacturers (2013-2018)
2.4. Manufacturers Botox Manufacturing Base Distribution, Sales Area and Product Type
2.5. Botox Market Competitive Situation and Trends
2.5.1. Botox Market Concentration Rate
2.5.2. Botox Market Share of Top 3 and Top 5 Manufacturers
2.5.3. Mergers & Acquisitions, Expansion

Purchase a copy of Botox Market visit @
http://orbisresearch.com/contact/purchase/2044081
For more information contact sales@orbisresearch.com

Chapter Three: Global Botox Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1. Global Botox Capacity and Market Share by Region (2013-2018)
3.2. Global Botox Production and Market Share by Region (2013-2018)
3.3. Global Botox Revenue (Value) and Market Share by Region (2013-2018)
3.4. Global Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5. North America Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6. Europe Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7. China Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8. Japan Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9. Southeast Asia Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10. India Botox Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

Chapter Four: Global Botox Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1. Global Botox Consumption by Region (2013-2018)
4.2. North America Botox Production, Consumption, Export, Import (2013-2018)
4.3. Europe Botox Production, Consumption, Export, Import (2013-2018)
4.4. China Botox Production, Consumption, Export, Import (2013-2018)
4.5. Japan Botox Production, Consumption, Export, Import (2013-2018)
4.6. Southeast Asia Botox Production, Consumption, Export, Import (2013-2018)
4.7. India Botox Production, Consumption, Export, Import (2013-2018)

Chapter Five: Global Botox Production, Revenue (Value), Price Trend by Type
5.1. Global Botox Production and Market Share by Type (2013-2018)
5.2. Global Botox Revenue and Market Share by Type (2013-2018)
5.3. Global Botox Price by Type (2013-2018)
5.4. Global Botox Production Growth by Type (2013-2018)

Related Report:United States Botox Market 2017 Industry Trend and Forecast 2022

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas
Phone: +1 (214) 884-6817

Source URL: https://marketersmedia.com/botox-market-2018-2023-global-demand-trend-key-manufacturers-growth-supply-analysis-and-industry-forecast-report/294559

For more information, please visit http://orbisresearch.com/reports/index/2018-market-research-report-on-global-botox-industry

Source: MarketersMedia

Release ID: 294559